1. Home
  2. CRIS vs MDCX Comparison

CRIS vs MDCX Comparison

Compare CRIS & MDCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRIS
  • MDCX
  • Stock Information
  • Founded
  • CRIS 2000
  • MDCX 2008
  • Country
  • CRIS United States
  • MDCX Canada
  • Employees
  • CRIS N/A
  • MDCX N/A
  • Industry
  • CRIS Biotechnology: Biological Products (No Diagnostic Substances)
  • MDCX
  • Sector
  • CRIS Health Care
  • MDCX
  • Exchange
  • CRIS Nasdaq
  • MDCX Nasdaq
  • Market Cap
  • CRIS 32.8M
  • MDCX 33.8M
  • IPO Year
  • CRIS 2000
  • MDCX N/A
  • Fundamental
  • Price
  • CRIS $3.21
  • MDCX $2.95
  • Analyst Decision
  • CRIS Strong Buy
  • MDCX Strong Buy
  • Analyst Count
  • CRIS 3
  • MDCX 1
  • Target Price
  • CRIS $23.00
  • MDCX $10.00
  • AVG Volume (30 Days)
  • CRIS 33.8K
  • MDCX 10.1K
  • Earning Date
  • CRIS 02-18-2025
  • MDCX 01-01-0001
  • Dividend Yield
  • CRIS N/A
  • MDCX N/A
  • EPS Growth
  • CRIS N/A
  • MDCX N/A
  • EPS
  • CRIS N/A
  • MDCX N/A
  • Revenue
  • CRIS $10,259,000.00
  • MDCX N/A
  • Revenue This Year
  • CRIS N/A
  • MDCX N/A
  • Revenue Next Year
  • CRIS N/A
  • MDCX N/A
  • P/E Ratio
  • CRIS N/A
  • MDCX N/A
  • Revenue Growth
  • CRIS 0.44
  • MDCX N/A
  • 52 Week Low
  • CRIS $2.86
  • MDCX $1.80
  • 52 Week High
  • CRIS $17.49
  • MDCX $3.23
  • Technical
  • Relative Strength Index (RSI)
  • CRIS 43.98
  • MDCX N/A
  • Support Level
  • CRIS $3.05
  • MDCX N/A
  • Resistance Level
  • CRIS $3.55
  • MDCX N/A
  • Average True Range (ATR)
  • CRIS 0.22
  • MDCX 0.00
  • MACD
  • CRIS 0.00
  • MDCX 0.00
  • Stochastic Oscillator
  • CRIS 26.67
  • MDCX 0.00

About CRIS Curis Inc.

Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.

About MDCX Medicus Pharma Ltd. Common Stock

Medicus Pharma Ltd is a clinical-stage, multi-strategy holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA approved clinical trials.

Share on Social Networks: